Concarlo Holdings, LLC
Concarlo Holdings, LLC, based in Brooklyn, NY, is dedicated to developing novel therapeutics aimed at transforming outcomes for cancer patients through cutting-edge innovations in p27 biology. The company stands out as a pioneer in targeting CDK46-driven cell proliferation and addressing CDK2-driven resistance, positioning itself as a leader in the fight against drug-resistant cancer.
Founded by Stacy Blain, Concarlo Therapeutics has garnered numerous accolades, including the Top Therapeutic Company award at the 2025 Aquillius Innovation in Women's Health Pitch Showcase. The organization is committed to advancing cancer treatment and has established a reputation for excellence in drug discovery and innovation within the biotechnology sector.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


